2.38
price up icon0.85%   0.02
after-market アフターアワーズ: 2.30 -0.08 -3.36%
loading
前日終値:
$2.36
開ける:
$2.4
24時間の取引高:
143.22K
Relative Volume:
1.03
時価総額:
$6.58M
収益:
-
当期純損益:
$-26.92M
株価収益率:
-4.6667
EPS:
-0.51
ネットキャッシュフロー:
$-18.92M
1週間 パフォーマンス:
+13.33%
1か月 パフォーマンス:
-67.78%
6か月 パフォーマンス:
-84.13%
1年 パフォーマンス:
-93.80%
1日の値動き範囲:
Value
$2.25
$2.40
1週間の範囲:
Value
$1.98
$2.78
52週間の値動き範囲:
Value
$1.98
$66.60

Cel-Sci Corp. Stock (CVM) Company Profile

Name
名前
Cel-Sci Corp.
Name
セクター
Healthcare (1170)
Name
電話
703-506-9460
Name
住所
8229 Boone Boulevard, Suite 802, Vienna, VA
Name
職員
0
Name
Twitter
@CelSciCorp
Name
次回の収益日
2025-02-18
Name
最新のSEC提出書
Name
CVM's Discussions on Twitter

CVM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CVM
Cel-Sci Corp.
2.38 6.58M 0 -26.92M -18.92M -0.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-01-13 開始されました H.C. Wainwright Buy
2015-03-02 開始されました Dawson James Buy

Cel-Sci Corp. (CVM) 最新ニュース

pulisher
May 30, 2025

CVM stock touches 52-week low at $2.32 amid sharp annual decline By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

CVM stock touches 52-week low at $2.32 amid sharp annual decline - Investing.com Australia

May 29, 2025
pulisher
May 23, 2025

CEL-SCI Closes $5 Million Public Offering - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Cancer Immunotherapy Firm CEL-SCI Secures $5M Funding to Advance Multikine Treatment - Stock Titan

May 23, 2025
pulisher
May 23, 2025

CVM Stock Offering Priced Below Previous Closing Value | CVM Stock News - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Dow Moves Higher; US Initial Jobless Claims Fall - Benzinga

May 22, 2025
pulisher
May 22, 2025

CEL-SCI (CVM) Prices Public Offering Amid Stock Slump - GuruFocus

May 22, 2025
pulisher
May 22, 2025

CEL-SCI Prices Offering of 2 Million Shares - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

CEL-SCI (CVM) Prepares to Submit Breakthrough Medicine Applicati - GuruFocus

May 22, 2025
pulisher
May 21, 2025

CVM Stock Offering Priced Below Previous Closing Value | CVM Sto - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Cel-Sci Says Prices Public Offering Of 2 Million Shares At $2.50 Per Share - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

CEL-SCI Raises $5M in New Stock Offering: Cancer Immunotherapy Program Multikine Gets Fresh Funding - Stock Titan

May 21, 2025
pulisher
May 21, 2025

CVM stock touches 52-week low at $4.67 amid sharp annual decline By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

CEL-SCI Announces Planned Public Offering; Shares Fall After Hours - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

CEL-SCI announces public stock offering to fund cancer therapy By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

CEL-SCI Corporation (CVM) Plans Public Offering for R&D and Corporate Needs | CVM Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

CEL-SCI announces public stock offering to fund cancer therapy - Investing.com

May 21, 2025
pulisher
May 21, 2025

CEL-SCI Announces Strategic Public Offering: Cancer Immunotherapy Development Gets Major Funding Push - Stock Titan

May 21, 2025
pulisher
May 21, 2025

CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia - BioSpace

May 21, 2025
pulisher
May 21, 2025

CVM stock touches 52-week low at $4.67 amid sharp annual decline - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

CEL-SCI Completes Saudi Breakthrough Medicine Designation Application for Multikine Cancer Drug - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

CEL-SCI seeks SFDA nod for cancer drug Multikine By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

CEL-SCI seeks SFDA nod for cancer drug Multikine - Investing.com

May 21, 2025
pulisher
May 21, 2025

CEL-SCI (CVM) Prepares to Submit Breakthrough Medicine Application in Saudi Arabia | CVM Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Revolutionary Cancer Drug Shows 73% Survival Rate, Nears Fast-Track Approval in Saudi Arabia - Stock Titan

May 21, 2025
pulisher
May 20, 2025

CEL-SCI Implements 1-for-30 Stock Split To Support Share Price - Nasdaq

May 20, 2025
pulisher
May 19, 2025

CEL-SCI approves 1-for-30 stock combination By Investing.com - Investing.com South Africa

May 19, 2025
pulisher
May 19, 2025

CEL-SCI (CVM) Approves 1-for-30 Stock Consolidation | CVM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

CEL-SCI approves 1-for-30 stock combination - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

CEL-SCI's Board Approves 1-for-30 Share Combination - marketscreener.com

May 19, 2025
pulisher
May 19, 2025

CEL-SCI Announces Combination of Common Stock | CVM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

CEL-SCI expects 1 for 30 combination of common stock to be implemented on May 20 - TipRanks

May 19, 2025
pulisher
May 19, 2025

CEL-SCI Plans Major 1:30 Reverse Split as CEO Hints at Upcoming Catalysts - Stock Titan

May 19, 2025
pulisher
May 16, 2025

StockNews.com Begins Coverage on CEL-SCI (NYSE:CVM) - Defense World

May 16, 2025
pulisher
May 15, 2025

CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results | C - GuruFocus

May 15, 2025
pulisher
May 15, 2025

CEL-SCI Cancer Drug Shows 95% Quality of Life Success in Phase 3 Trial | CVM Stock News - Stock Titan

May 15, 2025
pulisher
May 15, 2025

CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results - Business Wire

May 15, 2025
pulisher
May 15, 2025

Cel-Sci: Fiscal Q2 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 08, 2025

CEL-SCI (NYSE:CVM) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 08, 2025
pulisher
May 04, 2025

CEL-SCI Co. (NYSE:CVM) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025
pulisher
May 02, 2025

LD Micro 360 Companies --Set to Present this Week. - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

Take off with Cel-Sci Corp (CVM): Get ready for trading - Sete News

May 02, 2025
pulisher
May 02, 2025

Top investors say Ares Management Corp (ARES) ticks everything they need - Sete News

May 02, 2025
pulisher
May 01, 2025

A stock that deserves closer examination: Cel-Sci Corp (CVM) - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

Investing in Cel-Sci Corp (CVM) Is Getting More Attractive - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

CVM’s Stock Journey: What Investors Need to Know About Cel-Sci Corp’s Performance - investchronicle.com

Apr 30, 2025
pulisher
Apr 30, 2025

Curbline Properties Corp (CURB) Becoming More Attractive for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Metric Analysis: Coca-Cola Femsa S.A.B. DE C.V. ADR (KOF)’s Key Ratios in the Limelight - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Analyzing Ratios: Cel-Sci Corp (CVM)’s Financial Story Unveiled - DWinneX

Apr 30, 2025

Cel-Sci Corp. (CVM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):